Dissecting the genetic risk for coronary heart disease
Thomas Quertermous - William G. Irwin Professor in Cardiovascular Medicine
Bio-X Affiliated Faculty
The Quertermous laboratory is interested in the molecular mechanisms that mediate vascular disease pathophysiology and the risk for these diseases.
Other Stanford Bio-X Supported Research
Resetting the adipogenic/pro-inflammatory switch: a new way to treat insulin resistance
Supported BioSTAR Sponsored Research Project - 2013
Research News
Scientists make strides in hunt for genetic causes of heart disease
May 22, 2017 - Stanford Medicine Scope
Stanford cardiologist Tim Assimes and a consortium of scientists including Bio-X affiliate Tom Quertermous...
Pinpointing specific cells may help thwart congenital heart disease
November 10, 2016 - Stanford Medicine Scope
Bio-X affiliates Sean Wu, Stephen Quake, Philip Tsao, and Thomas Quertermous and their colleagues have...
Anti-tumor antibodies could counter atherosclerosis
July 14, 2016 - Stanford Medicine News Center
Bio-X affiliates Nicholas Leeper, Irv Weissman, and Thomas Quertermous find that a biological drug...